Nanobiotix S.A.
NBTX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $131 | $242 | $119 | $247 |
| - Cash | $50 | $75 | $41 | $84 |
| + Debt | $51 | $51 | $53 | $46 |
| Enterprise Value | $132 | $217 | $131 | $210 |
| Revenue | -$12 | $36 | $5 | $3 |
| % Growth | -132.1% | 658.1% | 80.4% | – |
| Gross Profit | -$12 | $36 | $4 | $3 |
| % Margin | 100% | 100% | 79.4% | 100% |
| EBITDA | -$58 | -$24 | -$44 | -$46 |
| % Margin | 502.4% | -65.4% | -925.8% | -1,722.9% |
| Net Income | -$68 | -$40 | -$57 | -$47 |
| % Margin | 586.9% | -109.6% | -1,194.4% | -1,775.7% |
| EPS Diluted | -1.44 | -1.08 | -1.64 | -1.35 |
| % Growth | -33.3% | 34.1% | -21.5% | – |
| Operating Cash Flow | -$20 | -$12 | -$37 | -$30 |
| Capital Expenditures | -$1 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$20 | -$13 | -$37 | -$30 |